MLYS - Wall Street Estimates - Mineralys Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 9.24

-2.74 %

$ 460 M

Market Cap

-2.79

P/E

Price Target Average

224.68%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

--0.72%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Mineralys Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for MLYS of $30 , with forecasts ranging from a low of $30 to a high of $30 .

MLYS Lowest Price Target Wall Street Target

30 USD 224.68%

MLYS Average Price Target Wall Street Target

30 USD 224.68%

MLYS Highest Price Target Wall Street Target

30 USD 224.68%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free